CME Group Analyst Price Targets - Benzinga

CME Group Inc

CMENASDAQ

Trade with Public

Trade with Public

$304.32

-2.92-0.95%

Ult. Agg.: Nov 5, 5:58 PM

Panoramica Notizie Previsioni utili EventiObiettivi di prezzoDati finanziari Sentiment Azionariato Dividendi Confronta Opzioni Rapporto azionario

CME Group Analyst Price Targets - Benzinga

CME Group Analyst Price Targets

Wall Street analyst price targets and consensus rating for CME Group (CME).

Price Target Range — 9 Quarters

Analyst Consensus — 17 Analysts

10Buy

6Hold

1Sell

Consensus RatingOverweight# Analysts17Avg. Consensus PT$303Upside to Avg. PT-0.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 22, 2026	UBS	Alex Kramm	PT Raise	Neutral	$270→$310
Oct 22, 2026	Morgan Stanley	Michael Cyprys	PT Raise	Overweight	$337→$359
Oct 22, 2026	Barclays	Benjamin Budish	PT Raise	Equal-Weight	$281→$321
Oct 22, 2026	Wells Fargo	Daniel Welden	PT Raise	Overweight	$315→$333
Oct 22, 2026	Piper Sandler	Patrick Moley	PT Raise	Overweight	$295→$330
Oct 22, 2026	JP Morgan	Kenneth Worthington	Upgrade	Underweight→Overweight	$367
Oct 14, 2026	Wells Fargo	Daniel Welden	PT Raise	Overweight	$301→$315
Oct 9, 2026	Morgan Stanley	Michael Cyprys	PT Raise	Overweight	$330→$337
Oct 7, 2026	Barclays	Benjamin Budish	PT Raise	Equal-Weight	$270→$281
Oct 5, 2026	UBS	Alex Kramm	PT Raise	Neutral	$260→$270
Oct 5, 2026	TD Cowen	Bill Katz	PT Raise	Buy	$292→$300
Oct 2, 2026	Wells Fargo	Daniel Welden	Initiate	Overweight	$301
Sep 28, 2026	TD Cowen	Bill Katz	Maintained	Buy	$292
Sep 3, 2026	TD Cowen	Bill Katz	Maintained	Buy	$292
Aug 19, 2026	Deutsche Bank	Brian Bedell	Downgrade	Buy→Hold	$286→$270
Jul 23, 2026	JP Morgan	Kenneth Worthington	PT Raise	Underweight	$249→$250
Jul 23, 2026	B of A Securities	Craig Siegenthaler	PT Raise	Underperform	$226→$230
Jul 23, 2026	Morgan Stanley	Michael Cyprys	PT Raise	Overweight	$324→$330
Jul 15, 2026	Piper Sandler	Patrick Moley	PT Cut	Overweight	$329→$295
Jul 10, 2026	Morgan Stanley	Michael Cyprys	PT Cut	Overweight	$353→$324

Analyst Ratings News

PRO
UBS Maintains Neutral on CME Group, Raises Price Target to $310

UBS analyst Alex Kramm maintains CME Group (NASDAQ:CME) with a Neutral and raises the price target from $270 to $310.

Benzinga Newsdesk

PRO
Morgan Stanley Maintains Overweight on CME Group, Raises Price Target to $359

Morgan Stanley analyst Michael Cyprys maintains CME Group (NASDAQ:CME) with a Overweight and raises the price target from $337 to $359.

Benzinga Newsdesk

This CME Group Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday

Analysts upgraded Ionis, CME Group, DigitalOcean, Prologis and Zions Bancorporation, issuing new or revised price targets.

Avi Kapoor

PRO
Barclays Maintains Equal-Weight on CME Group, Raises Price Target to $321

Barclays analyst Benjamin Budish maintains CME Group (NASDAQ:CME) with a Equal-Weight and raises the price target from $281 to $321.

Benzinga Newsdesk

PRO
Wells Fargo Maintains Overweight on CME Group, Raises Price Target to $333

Wells Fargo analyst Daniel Welden maintains CME Group (NASDAQ:CME) with a Overweight and raises the price target from $315 to $333.

Benzinga Newsdesk

PRO
Piper Sandler Reiterates Overweight on CME Group, Raises Price Target to $330

Piper Sandler analyst Patrick Moley reiterates CME Group (NASDAQ:CME) with a Overweight and raises the price target from $295 to $330.

Benzinga Newsdesk